Dipeptidyl peptidase-4 inhibitors may up pancreatic disease risk
(HealthDay)—Use of dipeptidyl peptidase-4 inhibitors (DPP-4i) is associated with increased risks for pancreatitis and pancreatic cancer in patients with newly diagnosed type 2 diabetes, according to a study published online ...
Aug 28, 2019
0
3